Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EF.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.59SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.56SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EW.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BW.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBZSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.79SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.25.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.69SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.70SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used